The U.S. FDA has granted Emergency Use Authorization for the high-throughput, low-cost MassARRAY SARS-CoV-2 Panel for in vitro diagnostic use. We enable laboratories to scale up molecular testing and respond effectively to this global crisis with a secure supply of instruments and assay reagents. Get started now!
More